Basket Trials: How Qualified Oncology CRAs Address & Overcome the Challenges
Basket trials, along with umbrella trials and platform trials, are classified as master protocols which investigate multiple hypothesis throughout concurrent…
Diversity in Clinical Trials – How to Attain It?
All agree that ethnic groups are massively under-represented when it comes to clinical trials, and although barriers to diversity in…
Assessing the Canadian Landscape for Cancer Research
Canada’s world-class researchers and diverse patient population make it one of the top 6 countries in the world for enrollment of…
eTMF Best Practice for a Lean Team
The TMF is the official record of the clinical study for Regulatory Authorities, be it the FDA, Health Canada, or…
Canada: For Your Phase 3 Global Trial Expansion
Oncology continues to be the largest and fastest growing therapeutic area in the clinical trials market, and a market dominated…
Doubly Nimble: why you should open global P1 clinical trials in Canada on Day 1
With agility increasingly becoming the most important global driver of success, it’s worth noting that Canadian oncology research center Phase…
Prime Location for Global Clinical Studies?
Canada is considered one of the most attractive places to live in the world, with a high quality of life,…
Why Not Canada for Your Phase 3 Global Trial Expansion?
Pre-pandemic oncology was both the largest and fastest growing therapeutic area in the clinical trials market. A key market trend…
Diversity in Clinical Trial Participants: Canada Holds Promise
Participant diversity in clinical trials can be quite challenging to achieve. With COVID the concern about appropriate demographic representation is…
Let Canada Contribute to Your Basket Trial Success
With the emergence of basket trials in the early-phase oncology setting, clinical research teams are faced with challenges of enrollment…